Restor3d has agreed to pay approximately $17m to acquire Conformis, its competitor in the 3D-printed orthopedics market.
It will purchase all outstanding common stock shares of Conformis at a price of $2.27 each
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?